越秀金控(000987.SZ):子公司越秀租賃擬發行不超30億元定向債務融資工具
格隆匯 3 月 22日丨越秀金控(000987.SZ)公佈,公司於2021年3月22日召開的第九屆董事會第十三次會議審議通過了《關於控股子公司越秀租賃發行定向債務融資工具的議案》,該事項尚需提交公司2021年第一次臨時股東大會審議。
為優化債務結構,越秀租賃擬通過中國銀行間市場交易商協會申請註冊發行定向債務融資工具(PPN)。此次擬向中國銀行間市場交易商協會申請註冊金額為不超過人民幣30億元(含30億)的定向債務融資工具,具體發行規模將以越秀租賃在中國銀行間市場交易商協會註冊的金額為準。此次發行的期限不超過5年(含5年);可以是單一期限品種,也可以是多種期限品種的組合。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.